Filing Details
- Accession Number:
- 0001765581-19-000100
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-09 17:19:51
- Reporting Period:
- 2019-12-05
- Accepted Time:
- 2019-12-09 17:19:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1784606 | Patricia Carr | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Vp, Finance & Pao | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2019-12-05 | 1,667 | $123.36 | 7,549 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2019-12-05 | 1,667 | $148.89 | 5,882 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2019-12-05 | 82 | $149.84 | 5,800 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Non-Qualified Stock Option (right to buy) | Disposition | 2019-12-05 | 1,667 | $0.00 | 1,667 | $123.36 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
313 | 2026-02-24 | No | 4 | M | Direct |
Footnotes
- Includes 82 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 29, 2019.
- These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.